Adiponectin levels and expression of adiponectin receptors in isolated monocytes from overweight patients with coronary artery disease.

[1]  山本 和美,et al.  Adiponectin prevents atherosclerosis by increasing cholesterol efflux from macrophages , 2011 .

[2]  G. Cockrell,et al.  Palmitate and insulin synergistically induce IL-6 expression in human monocytes , 2010, Cardiovascular diabetology.

[3]  M. Al-Omran,et al.  Adiponectin primes human monocytes into alternative anti-inflammatory M2 macrophages. , 2010, American journal of physiology. Heart and circulatory physiology.

[4]  J. Lekakis,et al.  Genetic variation in the adiponectin receptor 2 (ADIPOR2) gene is associated with coronary artery disease and increased ADIPOR2 expression in peripheral monocytes , 2010, Cardiovascular diabetology.

[5]  Yen-Wen Wu,et al.  Association of circulating matrix metalloproteinase-1, but not adiponectin, with advanced coronary artery disease. , 2009, Atherosclerosis.

[6]  T. Pang,et al.  The Distribution of Adiponectin Receptors on Human Peripheral Blood Mononuclear Cells , 2008, Annals of the New York Academy of Sciences.

[7]  R. Schnabel,et al.  Association of adiponectin with adverse outcome in coronary artery disease patients: results from the AtheroGene study. , 2008, European heart journal.

[8]  M. Reilly,et al.  Adipokines, insulin resistance, and coronary artery calcification. , 2008, Journal of the American College of Cardiology.

[9]  C. Buechler,et al.  Reduced response to adiponectin and lower abundance of adiponectin receptor proteins in type 2 diabetic monocytes , 2008, FEBS letters.

[10]  T. Funahashi,et al.  Prognostic value of adiponectin for cardiovascular disease and mortality. , 2008, The Journal of clinical endocrinology and metabolism.

[11]  C. Tsigos,et al.  Visfatin, TNF-α and IL-6 mRNA Expression is Increased in Mononuclear Cells from Type 2 Diabetic Women , 2007, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[12]  M. Rossi,et al.  Pattern of expression of adiponectin receptors in human adipose tissue depots and its relation to the metabolic state , 2007, International Journal of Obesity.

[13]  A. Tall,et al.  The Macrophage at the Crossroads of Insulin Resistance and Atherosclerosis , 2007, Circulation research.

[14]  E. Boutati,et al.  Glucose transporter expression on the plasma membrane of resting and activated white blood cells , 2007, European journal of clinical investigation.

[15]  N. Bukan,et al.  Decreased plasma adiponectin is associated with insulin resistance and HDL cholesterol in overweight subjects. , 2007, Endocrine journal.

[16]  W. März,et al.  Adiponectin and mortality in patients undergoing coronary angiography. , 2006, The Journal of clinical endocrinology and metabolism.

[17]  Vineet Chopra,et al.  Adiponectin is an independent predictor of all-cause mortality, cardiac mortality, and myocardial infarction in patients presenting with chest pain. , 2006, European heart journal.

[18]  H. Randeva,et al.  Upregulation of adiponectin receptor 1 and 2 mRNA and protein in adipose tissue and adipocytes in insulin-resistant women with polycystic ovary syndrome , 2006, Diabetologia.

[19]  C. Mantzoros,et al.  Circulating adiponectin and expression of adiponectin receptors in human skeletal muscle: associations with metabolic parameters and insulin resistance and regulation by physical training. , 2006, The Journal of clinical endocrinology and metabolism.

[20]  S. B. Pedersen,et al.  Adiponectin Receptors in Human Adipose Tissue: Effects of Obesity, Weight Loss, and Fat Depots , 2006, Obesity.

[21]  C. Tsatsanis,et al.  Adiponectin induces TNF-alpha and IL-6 in macrophages and promotes tolerance to itself and other pro-inflammatory stimuli. , 2005, Biochemical and biophysical research communications.

[22]  H. Brenner,et al.  Adiponectin, risk of coronary heart disease and correlations with cardiovascular risk markers. , 2005, European heart journal.

[23]  H. Tilg,et al.  Adiponectin induces the anti-inflammatory cytokines IL-10 and IL-1RA in human leukocytes. , 2004, Biochemical and biophysical research communications.

[24]  M. Stumvoll,et al.  Expression of adiponectin receptor mRNA in human skeletal muscle cells is related to in vivo parameters of glucose and lipid metabolism. , 2004, Diabetes.

[25]  S. Kihara,et al.  Adiponectin Specifically Increased Tissue Inhibitor of Metalloproteinase-1 Through Interleukin-10 Expression in Human Macrophages , 2004, Circulation.

[26]  E. Ravussin,et al.  Adiponectin receptors gene expression and insulin sensitivity in non-diabetic Mexican Americans with or without a family history of Type 2 diabetes , 2004, Diabetologia.

[27]  M. Wulster-Radcliffe,et al.  Adiponectin differentially regulates cytokines in porcine macrophages. , 2004, Biochemical and biophysical research communications.

[28]  R. Henry,et al.  Adiponectin: more than just another fat cell hormone? , 2003, Diabetes care.

[29]  Philippe Froguel,et al.  Cloning of adiponectin receptors that mediate antidiabetic metabolic effects , 2003, Nature.

[30]  S. Kihara,et al.  Association of Hypoadiponectinemia With Coronary Artery Disease in Men , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[31]  T. Funahashi,et al.  The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 2001 by The Endocrine Society Hypoadiponectinemia in Obesity and Type 2 Diabetes: Close Association with Insulin Resistance , 2022 .

[32]  S. Kihara,et al.  Adipocyte-Derived Plasma Protein, Adiponectin, Suppresses Lipid Accumulation and Class A Scavenger Receptor Expression in Human Monocyte-Derived Macrophages , 2001, Circulation.

[33]  T Nakamura,et al.  Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[34]  M. Matsuda,et al.  Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. , 1999, Diabetes care.

[35]  T Nakamura,et al.  Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. , 1999, Biochemical and biophysical research communications.

[36]  R. Turner,et al.  Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man , 1985, Diabetologia.

[37]  J. Schölmerich,et al.  Effects of the new adiponectin paralogous protein CTRP-3 and of LPS on cytokine release from monocytes of patients with type 2 diabetes mellitus. , 2010, Cytokine.

[38]  F. Romeo,et al.  Adiponectin isoforms are not associated with the severity of coronary atherosclerosis but with undiagnosed diabetes in patients affected by stable CAD. , 2009, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[39]  B. Staels,et al.  Expression of adiponectin receptors in human macrophages and regulation by agonists of the nuclear receptors PPARalpha, PPARgamma, and LXR. , 2004, Biochemical and biophysical research communications.

[40]  J. Schölmerich,et al.  Adiponectin-induced Secretion of Interleukin-6 (il-6), Monocyte Chemotactic Protein-1 (mcp-1, Ccl2) and Interleukin-8 (il-8, Cxcl8) Is Impaired in Monocytes from Patients with Type I Diabetes , 2022 .